ピーナッツアレルギーの世界市場2019-2023

◆英語タイトル:Global Peanut Allergy Market 2019-2023
◆商品コード:IRTNTR30114
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年11月20日
◆ページ数:110
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

ピーナッツアレルギーは、かゆみ、腹痛、はれ、くしゃみ、下痢、および心停止をもたらす一般的な食物アレルギーの1つです。ピーナッツアレルギーの世界市場は、2019~2023年の間、年平均成長率89.68%で成長すると予測されています。

主な分析対象企業は、Aimmune Therapeutics、Aravax、DBV Technologies、HAL Allergy、Immunomic Therapeuticsなどです。

当調査レポートでは、ピーナッツアレルギーの世界市場について調査・分析し、市場概要、市場環境、ピーナッツアレルギー市場規模、製品別(ピーナッツタンパク質、ワクチン、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。

・エグゼクティブサマリー
・調査範囲・調査手法
・ピーナッツアレルギーの世界市場概要
・ピーナッツアレルギーの世界市場環境
・ピーナッツアレルギーの世界市場動向
・ピーナッツアレルギーの世界市場規模
・ピーナッツアレルギーの世界市場:業界構造分析
・ピーナッツアレルギーの世界市場:製品別(ピーナッツタンパク質、ワクチン、その他)
・ピーナッツアレルギーの世界市場:地域別市場規模・分析
・ピーナッツアレルギーの北米市場規模・予測
・ピーナッツアレルギーのヨーロッパ・中東・アフリカ市場規模・予測
・ピーナッツアレルギーのアジア太平洋市場規模・予測
・ピーナッツアレルギーの主要国分析
・ピーナッツアレルギーの世界市場:意思決定フレームワーク
・ピーナッツアレルギーの世界市場:成長要因、課題
・ピーナッツアレルギーの世界市場:競争環境
・ピーナッツアレルギーの世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About Peanut Allergy
Peanut allergy is one of the most common types of food allergies that results in itchiness, abdominal pain, swelling, sneezing, diarrhea, and cardiac arrest.
Technavio’s analysts forecast the Global Peanut Allergy Market to grow at a CAGR of 89.68% during the period 2019-2023.

[Covered in this report]
The report covers the present scenario and the growth prospects of the peanut allergy market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of peanut allergy across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, peanut allergy market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendor
• Aimmune Therapeutics
• Aravax
• DBV Technologies
• HAL Allergy
• Immunomic Therapeutics
Market driver
• Increase in collaborations for R&D
• For a full, detailed list, view our report

Market challenge
• Avoiding the consumption of peanuts
• For a full, detailed list, view our report

Market trend
• Business strategy framework in form of spin-offs
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Peanut protein – Market size and forecast 2018-2023
• Vaccine – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aimmune Therapeutics
• Aravax
• DBV Technologies
• HAL Allergy
• Immunomic Therapeutics
PART 15: APPENDIX
• Research methodology
• List of abbreviations
PART 16: EXPLORE TECHNAVIO


Exhibit 01: Global food allergy market
Exhibit 02: Segments of global food allergy market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Global peanut allergy market pipeline: Overview
Exhibit 18: Peanut allergy market pipeline: Overview
Exhibit 19: Product – Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Peanut protein – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Peanut protein – Year-over-year growth 2019-2023 (%)
Exhibit 23: Vaccine – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Vaccine – Year-over-year growth 2019-2023 (%)
Exhibit 25: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Others – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 33: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 35: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Molecules in late-stage development
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Spin-off companies and their funding agencies
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Aimmune Therapeutics – Vendor overview
Exhibit 48: Aimmune Therapeutics – Business segments
Exhibit 49: Aimmune Therapeutics – Organizational developments
Exhibit 50: Aimmune Therapeutics – Segment focus
Exhibit 51: Aimmune Therapeutics – Key offerings
Exhibit 52: Aimmune Therapeutics – Key customers
Exhibit 53: Aravax – Vendor overview
Exhibit 54: Aravax – Business segments
Exhibit 55: Aravax – Organizational developments
Exhibit 56: Aravax – Segment focus
Exhibit 57: Aravax – Key offerings
Exhibit 58: Aravax – Key customers
Exhibit 59: DBV Technologies – Vendor overview
Exhibit 60: DBV Technologies – Business segments
Exhibit 61: DBV Technologies – Organizational developments
Exhibit 62: DBV Technologies – Geographic focus
Exhibit 63: DBV Technologies – Segment focus
Exhibit 64: DBV Technologies – Key offerings
Exhibit 65: DBV Technologies – Key customers
Exhibit 66: HAL Allergy – Vendor overview
Exhibit 67: HAL Allergy – Business segments
Exhibit 68: HAL Allergy – Organizational developments
Exhibit 69: HAL Allergy – Key offerings
Exhibit 70: HAL Allergy – Key customers
Exhibit 71: Immunomic Therapeutics – Vendor overview
Exhibit 72: Immunomic Therapeutics – Business segments
Exhibit 73: Immunomic Therapeutics – Organizational developments
Exhibit 74: Immunomic Therapeutics – Key offerings
Exhibit 75: Immunomic Therapeutics – Key customers
Exhibit 76: Validation techniques employed for market sizing
Exhibit 77: List of abbreviations



【掲載企業】

Aimmune Therapeutics、Aravax、DBV Technologies、HAL Allergy、Immunomic Therapeutics

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ピーナッツアレルギーの世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆